Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Mergers and Acquisitions

Project details

Singaporean ophthalmic disease treatment company seeks investment.

Project region Singapore
Industry Biomedicine
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

David Stepat
Country Director, Singapore
Project highlights ophthalmic diseases - 6 treatment centers - profitable
Project description

The Singaporean company focuses on the treatment of ophthalmic diseases, including corneal transplantation, retinal surgery, myopia control and so on. There are 6 local professional treatment centers and 11 senior ophthalmologists. As of May 2021, the net profit after salaries is approximately USD 7.28 million (SGD 10 million). Now the company seeks investment.

Get in touch

We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.

Have Any Questions?

Reach out to our local experts, we’ll respond within one business day.

captcha image

Our Clients

Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.

See what our clients say about us

It appears that you have recently submitted an inquiry on this topic. Would you like to
replace your previous submission with this one?